About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Study of MRA in Patients With Rheumatoid Arthritis (RA)

NCT00144651·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Chugai Pharmaceutical

Age

20–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Patients administered MRA more than 2 times in preceding study, MRA009JP, and evaluated the efficacy and the safety.
Patients confirmed to have shown the safety in the preceding study.

You may not be if

Patients with Class IV Steinbrocker functional activity at evaluation within 4 weeks before treatment with the study drug
Patients who received any of the following treatments between the start of preceding study and the registration of this study.
1. Plasma exchange therapy
2. Surgical treatment (e.g., operation)

The record

StatusCompleted

PhasePhase 2

Taking part135

StartedAug 2001

UpdatedAug 9, 2013

Conditions

Rheumatoid Arthritis

Clareo Health | Study of MRA in Patients With Rheumatoid Arthritis (RA)